Day One Biopharmaceuticals Quote - DAWN

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

13.54

Bid

13.25

Ask

13.60

Volume

648,547

13.2036 Day's Range 13.79

11.30 52 Week Range 18.0699

Market Cap

1.365B

Previous Close

13.42

Open

13.48

Last Trade

13.26

Last Trade Time

Financial Volume

US$ 8,673,317

VWAP

13.3735

Average Volume (3m)

1,081,394

Shares Outstanding

100,846,294

Dividend Yield

PE Ratio

-7.23

Earnings Per Share (EPS)

-1.87

Revenue

Net Profit

-188.92M

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with c... Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.dayonebio.com

Headquarters

Wilmington, Delaware, USA

Founded

Day One Biopharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DAWN. The last closing price for Day One Biopharmaceuticals was US$13.42. Over the last year, Day One Biopharmaceuticals shares have traded in a share price range of US$ 11.30 to US$ 18.0699.

Day One Biopharmaceuticals currently has 100,846,294 shares outstanding. The market capitalization of Day One Biopharmaceuticals is US$1.35 billion. Day One Biopharmaceuticals has a price to earnings ratio (PE ratio) of -7.23.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.4	3.04414003044	13.14	14.16	13.03	817033	13.51860859	CS
4	-0.93	-6.42709053214	14.47	16.76	12.8631	1312960	14.63362843	CS
12	-0.25	-1.81290790428	13.79	16.76	12.8631	1081394	14.36165509	CS
26	-0.26	-1.88405797101	13.8	16.76	11.94	1021800	14.19011539	CS
52	1.39	11.4403292181	12.15	18.0699	11.3	916627	14.57877736	CS
156	-4.05	-23.0244457078	17.59	28.3499	5.44	829930	15.10994288	CS
260	-11.46	-45.84	25	28.699	5.44	727091	15.29242113	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PSTXPoseida Therapeutics Inc	US$ 9.38 (227.97%)	30.14M
IMGCIMG Inc	US$ 1.615 (156.35%)	114.51M
IDAIT Stamp Inc	US$ 0.364 (102.22%)	560.18M
PGHLPrimega Group Holdings Ltd	US$ 20.95 (98.77%)	2.89M
TOYOTOYO Company Ltd	US$ 5.41 (86.55%)	49.09M
ALECAlector Inc	US$ 2.575 (-34.97%)	8.13M
ABVEAbove Food Ingredients Inc	US$ 0.5338 (-34.42%)	1.66M
LGCLLucas GC Ltd	US$ 0.7511 (-33.53%)	2.48M
ADDColor Star Technology Company Ltd	US$ 4.19 (-31.87%)	205.78k
LESLLeslies Inc	US$ 2.445 (-30.34%)	24.55M
IDAIT Stamp Inc	US$ 0.364 (102.22%)	549.04M
ELABElevai Labs Inc	US$ 0.01255 (-21.07%)	323.24M
NVDANVIDIA Corporation	US$ 136.92 (0.66%)	186M
RGTIRigetti Computing Inc	US$ 2.195 (-20.18%)	124.14M
IMGCIMG Inc	US$ 1.615 (156.35%)	114.46M

Guzzi62 4 minutes ago

OS grew 43,000,000 in Q3 alone. That's 3.5%. This management team depreciated the value of your investment by 3.5% in one quarter alone, with just equity distribution. Forget the price plummeting. If you own 100,000 shares, they just reached into your pocket and grabbed 3500 shares for themselves fo

NWBO

bri123 4 minutes ago

Total Shi*show. no matter whom runs it. maybe we get a year-end-run good enough to get my money back (that's my Christmas wish).

THBD

BDEZ 5 minutes ago

Yeah, before Tucker was let go i'm sure...

BDEZ 6 minutes ago

Never saw that one! Thanks CT!

joyceschoice 6 minutes ago

Doublethink, not doublespeak. It's been long time since I last read it. Anyway it's 2024, not 1984 and here we are.

dinogreeves 7 minutes ago

All debt paid off. Lets see their game plan now.

https://www.otcmarkets.com/filing/html?id=18006601&guid=FQY-kHnuV5SJh3h

SMCI

littlejohn 7 minutes ago

VRT is selling at about 3 times higher

valuation rate on forward p/e projected...

https://finance.yahoo.com/quote/SMCI/key-statistics/

https://finance.yahoo.com/quote/VRT/key-statistics/

SMCI has a Charles Liang as CEO...

VRT

SMCI VRT

Crapola2theleft 7 minutes ago

It's about TIME! The ps will jump. Best of all, lives will start being saved!!!

NWBO

Talon38 7 minutes ago

Ignatius.....Although the EMA may not require a commercial pathway/plan, one could see they would want to see one in place when it was a major Alzheimer's drug they approved.

AVXL

Golden Cross 9 minutes ago

$BQST BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL
https://www.accesswire.com/947312/bioquest-inc-and-botmakers-expand-ai-marketing-services-with-speedleads-xl-and-marketscope-xl

BQST

ChannelTrader 9 minutes ago

Don't know but it's good.

JPetroInc 10 minutes ago

celebrity involvement …???

I was thinking more along the lines of a few guppy celeb’s or something

but no…MONI is swimming with internationally acclaimed celebrity “whales” with $20-Mil. and $10-Bil. net worths - are they kidding ….?

simple unreal AB…!

MONI

boston127 10 minutes ago

Do not give up. The managemt is good.

- They got out of China (Hong Kong) after realizing that most listed Chinese companies are full of hot air and "unclean" financials.
- They are in highly respected Singapore, which is more demanding about financials.
- They are

LGHL

SSKILLZ1 10 minutes ago

Pitching is starting to sign. Dodgers just signed Snell to a monster 5/182 million deal, they sure do spend money. A couple of days back Angels sign Kikuchi for 3/63. Hopefully soto signs soon, so mets whether they get him or not (Hopefully they get him) starting filling in the massive holes in the

gfp927z 10 minutes ago

Bar, I haven't owned it, but did have a number of Berkshire's stock holdings in my own portfolio. With Apple, Buffet had always shunned tech stocks, but he said that Apple was an exception due to the amazingly strong brand loyalty that it had with its users. But it's still tech, and subject to

JohnnyRotton 10 minutes ago

If the gold is minable, it will go up, if it isn't it won't.

Buy at .0001

NBRI

Rocky3 11 minutes ago

the partner will share development costs or take it on entirely, enta will retain a stake in the asset, and suddenly you are at 18 cash plus royalty, plus value of the RSV asset

For the record, the shareholder equity is down from ~$10/sh to ~$6/sh over the last 12 months. I know that

ENTA

oneragman 11 minutes ago

Sleven, the buyback and every other "action" taken by management has been a con. I mean what the hell was that investor conference? I didn't need someone to tell me how great the drug is. I need someone to tell me how they are going to make money. At this point, what is the plan? They just had an in

AMRN

dmsrz8 11 minutes ago

So not a lot of comments here of late. Looks promising

PODC

Genz2 11 minutes ago

Methinks, coming up on this thanksgiving, my mother went into a long term care facility and she got to see her favorite person, Donald Trump win the election!! I am thankful for that as I think she wouldn’t have made it this far if he lost!! I am absolutely CONVINCED that she is his #1

FFFacts 12 minutes ago

Quit posting links to your stupid x account. If you want to post from x learn to embed it so people dont have to click on your stupid link.

FNMA

BDEZ 12 minutes ago

Great clip, thanks CT. Wonder when that was?

Shows Tucker on Foxweiser...

BamaBreeze 13 minutes ago

You also!! And other positive shareholders. Maybe another pump will happen (and be true and honest)!

BLLB

hardlesson 13 minutes ago

Lol, well you won't have to worry about that, because you changed your sell order at .001, down to .0009 today, as you were the first one to point them out.

Except you weren't expecting such an appetite for more at .0009, and .0008.

Whether we hold this area or don't,

SHMN

	Real-time Prices	Level 2
Dow Jones Indices
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange
OTCBB
New York Stock Exchange
NASDAQ
American Stock Exchange
OTCMarkets
Canadian Securities Exchange
OPRA
OPRA Indices
Forex

	Real-time Prices	Level 2
Toronto Stock Exchange
Toronto Stock Exchange Venture Exchange

BLACK FRIDAY

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Day One Biopharmaceuticals Inc (DAWN) Share Price

Day One Biopharmaceuticals Inc (DAWN)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Day One Biopharmaceuticals Inc

Ask ADVFN Intelligence (AI)

DAWN Latest News

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%